TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HR-positive,HER2-negative in Advanced Breast Cancer
Interventions: DRUG: TQB3616 capsules|DRUG: TQB3616-matching placebo|DRUG: Fluvestrin injection
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.